Market Timing with TurnerTrends Provides Great Stock Picks for the Sophisticated Investor   Timing the Market well requires Stock Picks that work

TurnerTrends Stock Rating Report for CERS

Data valid for week beginning July 14, 2008

Ticker Company Name
CERS   [News] Cerus Corporation
Company Profile
"Cerus Corporation, a biomedical products company, engages in the development and commercialization of the INTERCEPT Blood System. The company's INTERCEPT Blood System is designed to target and inactivate blood-borne pathogens, such as viruses, bacteria, and parasites, as well as harmful white blood cells. It markets the INTERCEPT system for platelets and plasma in Europe and the Middle East. The company is also developing INTERCEPT Blood System for red blood cells or red blood cell system, which is designed to inactivate blood-borne pathogens in donated red blood cells for transfusion. It has collaboration agreements with Baxter International, Inc.- and BioOne Corporation. The company was founded in 1991 and is based in Concord, California."

Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.

CERS Technical Chart

We use technical analysis and fundamental analysis to recommend ratings for thousands of stocks. If you had a subscription, this space would show our 3 year history of trades for CERS. However, we only show it to our subscribers.

We update our ratings and stop losses EVERY WEEK.

Don't miss out on what we recommend for Cerus Corporation next week. Sign up today and start making money!

FREE TRIAL!!


Stock Information
Friday's Close $4.45
Volume Avg. 189620 shares
Industry Biotechnology
Sector Healthcare
Our Stop Loss Members Only
Expected Move Members Only
Optionable? Yes

Want to take a more "hands off" approach to investing with TurnerTrends? Try our managed accounts and hedge fund at Sabinal Capital Investments
Stock Financials
Profit Margin .00%
Operating Margin -241.14%
Debt-to-Equity .00%
P/E ttm 0.00
EPS ttm $-1.370
EBITDA $-32,510,000
Total Revenue $13,760,000
Market Cap $149,690
Annual Dividend $.00
Yield .000%
ROE -50.75%
Revenue Growth Rate Quarterly 120.70%
Earnings Growth Rate Quarterly 12.90%
Earnings Growth Rate Yearly 0.00%
Revenue Growth Rate Average 5.40%
Earnings Growth Rate Average 0.00%
Institutional Ownership Members Only
Value Rating Members Only
TurnerTrends Score Members Only


Latest News

Thu, 17 Jul 2008 13:10:47 Etc/GMTCerus Earnings Call scheduled for Thu, July 31 (CCBN)
Thu, 17 Jul 2008 10:00:00 Etc/GMTCerus Corporation to Release Second Quarter Financial Results (Business Wire)
Tue, 24 Jun 2008 14:35:06 Etc/GMTOnyx CFO submits resignation (at bizjournals.com)
Mon, 23 Jun 2008 22:45:07 Etc/GMTOnyx CFO submits resignation (at bizjournals.com)
Thu, 19 Jun 2008 21:14:12 Etc/GMTCERUS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation (EDGAR Online)
Thu, 19 Jun 2008 18:45:09 Etc/GMTCerus Corp. sets up $10M credit line with Wells Fargo (at bizjournals.com)
Thu, 19 Jun 2008 11:00:00 Etc/GMTCerus Secures $10 Million Revolving Credit Facility (Business Wire)
Wed, 11 Jun 2008 17:15:15 Etc/GMTCerus Corp. to supply blood safety system to German Red Cross (at bizjournals.com)
Wed, 11 Jun 2008 14:33:49 Etc/GMTCERUS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)
Wed, 11 Jun 2008 11:00:00 Etc/GMTCerus Enters into Agreement to Supply INTERCEPT Platelet System to Largest Region of German Red Cross (Business Wire)
Mon, 9 Jun 2008 11:00:00 Etc/GMTCerus Announces INTERCEPT Blood System Data Presented at International Society of Blood Transfusion Conference Support Broad Utility in Safeguarding the Blood Supply (Business Wire)
Fri, 6 Jun 2008 16:42:05 Etc/GMTCERUS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (EDGAR Online)
Mon, 2 Jun 2008 20:05:09 Etc/GMTBerkeley's Oncologic merges with Triton BioSystems (at bizjournals.com)
Sat, 10 May 2008 13:05:05 Etc/GMTCERUS CORP Financials (EDGAR Online Financials)
Tue, 6 May 2008 20:31:03 Etc/GMTCERUS CORP Files SEC form 10-Q, Quarterly Report (EDGAR Online)
Tue, 6 May 2008 11:30:00 Etc/GMTCerus to Present at Upcoming Investor Conferences in May (Business Wire)
Fri, 2 May 2008 19:19:45 Etc/GMTFriday's Health Winners & Losers (at TheStreet.com)
Fri, 2 May 2008 11:18:56 Etc/GMTCerus downgraded by JMP Securities (Briefing.com)
Thu, 1 May 2008 20:12:34 Etc/GMTCERUS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (EDGAR Online)
Thu, 1 May 2008 20:01:00 Etc/GMTCerus Corporation Announces First Quarter Financial Results (Business Wire)
News provided by Yahoo! Finance